PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era-Reference-Cited by-同舟云学术

PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

Published:2013-01 Issue:1 Volume:85 Page:e39-e46
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

McGuire Sean E.,Lee Andrew K.,Cerne Jasmina Z.,Munsell Mark F.,Levy Lawrence B.,Kudchadker Rajat J.,Choi Seungtaek L.,Nguyen Quynh N.,Hoffman Karen E.,Pugh Thomas J.,Frank Steven J.,Corn Paul G.,Logothetis Christopher J.,Kuban Deborah A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiation therapy in locally advanced carcinoma of the prostate;Pilepich;Int J Radiat Oncol Biol Phys,2001

2. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomized trial;Bolla;Lancet,2002

3. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group protocol 92-02;Hanks;J Clin Oncol,2003

4. 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial;D'Amico;JAMA,2004

5. Androgen suppression adjuvant to radiotherapy in prostate carcinoma–long-term results of phase III RTOG 85-31;Pilepich;Int J Radiat Oncol Biol Phys,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive Radiotherapy;Clinical Nuclear Medicine;2024-05-31

2. Hypofractionated radiation therapy combined with androgen deprivation therapy for high‐risk localized prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-03-13

3. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control;Radiotherapy and Oncology;2024-02

4. Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3;Biomarker Research;2022-07-13